Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Zhu, Hongming  [Clear All Filters]
2024
Jin W, Dai Y, Chen L, Zhu H, Dong F, Zhu H, Meng G, Li J, Chen S, Chen Z, et al. Cellular hierarchy insights reveal leukemic stem-like cells and early death risk in acute promyelocytic leukemia. Nat Commun. 2024;15(1):1423.
2023
Wang X, Zhu H, Chen D, Yu Y, Liu Q, Liu Q. A complete graph-based approach with multi-task learning for predicting synergistic drug combinations. Bioinformatics. 2023.
Zhu H, Chen J, Liu K, Gao L, Wu H, Ma L, Zhou J, Liu Z, Han J-DJ. Human PBMC scRNA-seq-based aging clocks reveal ribosome to inflammation balance as a single-cell aging hallmark and super longevity. Sci Adv. 2023;9(26):eabq7599.
Chen D, Wang X, Zhu H, Jiang Y, Li Y, Liu Q, Liu Q. Predicting anticancer synergistic drug combinations based on multi-task learning. BMC Bioinformatics. 2023;24(1):448.
2020
Ou T, Yang W, Li W, Lu Y, Dong Z, Zhu H, Sun X, Dong Z, Weng X, Chang S, et al. SIRT5 deficiency enhances the proliferative and therapeutic capacities of adipose-derived mesenchymal stem cells via metabolic switching. Clin Transl Med. 2020;10(5):e172.
2019
Li X, Dong Y, Li Y, Ren R, Wu W, Zhu H, Zhang Y, Hu J, Li J. Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study. BMC Cancer. 2019;19(1):819.
2018
Liang X, Ding Y, Lin F, Zhang Y, Zhou X, Meng Q, Lu X, Jiang G, Zhu H, Chen Y, et al. Overexpression of ERBB4 rejuvenates aged mesenchymal stem cell and enhances angiogenesis via PI3K/AKT and MAPK/ERK pathway. FASEB J. 2018:fj201801690R.
2014
Zhu H, Sun A, Zhu H, Li Z, Huang Z, Zou Y, Hu K, Ge J. Aldehyde Dehydrogenase-2 Is a Host Factor Required for Effective Bone Marrow Mesenchymal Stem Cell Therapy. Arterioscler Thromb Vasc Biol. 2014.